MedPath

Calcipotriene

Calcipotriene Topical Solution, 0.005% (Scalp Solution)

Approved
Approval ID

53c9942a-e861-493f-95c2-53446bc5f06d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 19, 2022

Manufacturers
FDA

Akorn

DUNS: 117696873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calcipotriene

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50383-732
Application NumberANDA077579
Product Classification
M
Marketing Category
C73584
G
Generic Name
Calcipotriene
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 4, 2022
FDA Product Classification

INGREDIENTS (7)

ISOPROPYL ALCOHOLInactive
Code: ND2M416302
Classification: IACT
MENTHOL, UNSPECIFIED FORMInactive
Code: L7T10EIP3A
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
CALCIPOTRIENE HYDRATEActive
Quantity: 0.05 mg in 1 mL
Code: S7499TYY6G
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calcipotriene - FDA Drug Approval Details